STOCK TITAN

Regional Health Prtys (RHEP) Financials

RHEP OTC
Trailing 12 months to September 30, 2026
Revenue $91.4M +140.2% YoY
Net Income -$91K n/m YoY
EPS (Diluted) $0.24 YoY not available
Free Cash Flow -$564K n/m YoY
Market Cap $3.6M as of Nov 12, 2026
Price / Sales 0.0x on $91.4M revenue, trailing 12 months to September 30, 2026
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to September 30, 2026
Price / Book n/m negative shareholder equity, so no book multiple, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 13, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the RHEP SEC filings page.

Regional Health Prtys Inc (RHEP) reported $91.4M in revenue over the twelve months to Sep 30, 2026, up 140.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RHEP FY2025

FY2025's reported profit arrived alongside negative operating cash flow, revealing that growth has not yet converted into internally generated cash.

FY2025 net income of $3.0M coexisted with operating cash flow of -$2.3M, so the accounting profit did not translate into operating cash. With free cash flow also at -$3.1M, earnings were a poor proxy for cash available to reinvest.

Revenue expanded to $53.2M from $18.3M in FY2024, but selling, general and administrative costs also rose to $12.0M from $5.4M. The resulting 3.1% operating margin shows that the larger revenue base still provides only a thin operating cushion.

Liabilities were 92.6% of assets, while a 0.7x current ratio indicates short-term obligations exceeded near-term assets. Receivables rose from $3.4M to $8.0M, while capital expenditures were only $869K, suggesting the cash shortfall was driven more by working-capital absorption than unusually heavy reinvestment.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Regional Health Prtys Inc, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Altman Z-Score Distress
-0.93

Regional Health Prtys Inc scores -0.93, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $81.8M against total assets of $67.8M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/8

Regional Health Prtys Inc passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.

Earnings Quality No Cash Backing

For every $1 of reported earnings, Regional Health Prtys Inc used $0.74 of operating cash (-$2.3M OCF vs $3.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Interest Coverage At Risk
0.62x

Regional Health Prtys Inc earns $0.62 in operating income for every $1 of interest expense ($1.7M vs $2.7M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$25.0M
YoY+65.2%
QoQ+2.3%
5Y CAGR+30.1%
10Y CAGR+13.3%

Regional Health Prtys Inc generated $25.0M in revenue in Q3 2026. This represents an increase of 65.2% from the same quarter a year earlier. Against the prior quarter it is up 2.3%.

EBITDA
$654K
YoYn/m
QoQ+20.9%
5Y CAGR-12.2%
10Y CAGR-14.5%

Regional Health Prtys Inc's EBITDA was $654K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 20.9%.

Net Income
-$851K
YoY-125.2%
QoQn/m
5Y CAGRn/m

Regional Health Prtys Inc reported a net loss of $851K in Q3 2026. This represents a decrease of 125.2% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.22
YoY-118.8%
QoQn/m

Regional Health Prtys Inc earned -$0.22 per diluted share (EPS) in Q3 2026. This represents a decrease of 118.8% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Free Cash Flow
$1.3M
YoYn/m
QoQ+45.4%
5Y CAGR-5.1%

Regional Health Prtys Inc generated $1.3M in free cash flow in Q3 2026, representing cash available after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 45.4%.

Cash & Debt
$1.7M
YoY+70.0%
QoQ0.0%
5Y CAGR-22.8%
10Y CAGR+1.6%

Regional Health Prtys Inc held $1.7M in cash against $33.8M in long-term debt as of Q3 2026.

Shares Outstanding
4M
YoY-0.3%
QoQ0.0%

Regional Health Prtys Inc had 4M shares outstanding in Q3 2026. This represents a decrease of 0.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Operating Margin
-0.5%
YoY+3.4pp
QoQ+0.4pp
5Y change-9.6pp
10Y change-28.8pp

Regional Health Prtys Inc's operating margin was -0.5% in Q3 2026, reflecting core business profitability. This is up 3.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.4 percentage points.

Net Margin
-3.4%
YoY-25.7pp
QoQ-0.2pp
5Y change-2.8pp

Regional Health Prtys Inc's net profit margin was -3.4% in Q3 2026, showing the share of revenue converted to profit. This is down 25.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.2 percentage points.

Gross Margin

Not reported for Q3 2026.

Return on Equity

Not reported for Q3 2026.

Capital Allocation

Capital Expenditures
$706K
YoY+149.5%
QoQ+41.8%
5Y CAGR+73.4%

Regional Health Prtys Inc invested $706K in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 149.5% from the same quarter a year earlier. Against the prior quarter it is up 41.8%.

R&D Spending

Not reported for Q3 2026.

Share Buybacks

Not reported for Q3 2026.

RHEP Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RHEP quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$25.0M+65.2%$24.4M+143.0%$21.2M+194.3%$20.8M+267.2%$15.1M+258.3%$10.1M+132.5%$7.2M+74.2%$5.7M+25.1%
SG&A Expenses$6.6M+76.9%$6.7M+175.7%$6.5M+192.2%$3.7M+177.2%$3.7M+203.3%$2.4M+97.6%$2.2M+36.7%$1.3M+17.1%
Operating Income-$131Kn/m-$216Kn/m-$702Kn/m$3.1M+470.1%-$594Kn/m-$508K-337.4%-$318Kn/m$541K+240.3%
EBITDA$654Kn/m$541Kn/m$20K-76.2%$3.8M+243.8%-$47K-127.0%-$105K-114.4%$84K-61.3%$1.1M+63.3%
Interest Expense$576K-23.3%$567K-7.8%$522K-20.1%$652K-5.5%$751K+10.9%$615K-8.1%$653K-3.1%$690K+0.9%
Net Income-$851K-125.2%-$782Kn/m-$1.2Mn/m$2.7Mn/m$3.4Mn/m-$1.4Mn/m-$1.9Mn/m-$568Kn/m
EPS (Basic)-$0.22-118.8%-$0.20-$0.29$0.95$1.17-$0.68n/m-$0.94n/m-$0.31n/m
EPS (Diluted)-$0.22-118.8%-$0.20-$0.29$0.95$1.17-$0.68n/m-$0.94n/m-$0.31n/m
Diluted Shares (Avg)4M+25.6%4M4MN/A3M2M+16.0%2M+8.4%N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Income Tax.

RHEP Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RHEP quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$67.5M-6.4%$68.0M+13.0%$67.3M+13.5%$67.8M+12.1%$72.2M+20.1%$60.1M-1.9%$59.3M-3.2%$60.5M-2.8%
Current Assets$18.0M$17.7M$16.2M$16.3M+138.8%N/AN/AN/A$6.8M
Cash & Equivalents$1.7M+70.0%$1.7M+325.0%$1.1M+120.0%$3.0M+415.5%$1.0M+100.0%$400K-42.9%$500K-37.5%$582K-41.8%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Inventory$1.5M+2.0%$1.5M$1.6M$1.4M$1.4MN/AN/AN/A
Accounts Receivable$10.6M+38.0%$10.3M+135.7%$10.1M+176.3%$8.0M+138.7%$7.7M+279.3%$4.4M+140.3%$3.6M+148.6%$3.4M+140.1%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Goodwill$1.6M0.0%$1.6M0.0%$1.6M0.0%$1.6M0.0%$1.6M0.0%$1.6M0.0%$1.6M0.0%$1.6M0.0%
Total Liabilities$65.4M-5.2%$65.0M-0.9%$63.6M+0.2%$62.8M-1.0%$69.0M+10.5%$65.6M+4.6%$63.4M+2.4%$63.4M+2.2%
Current Liabilities$28.0M$27.1M$25.3M$24.2M+18.4%N/AN/AN/A$20.4M
Non-Current Liabilities$37.4M$37.9M$38.3M$38.6M-10.1%N/AN/AN/A$43.0M
Long-Term Debt$33.8M-30.3%$34.1M-30.2%$34.5M-29.7%$34.7M-11.6%$48.6M-2.2%$48.9M-2.6%$49.2M-1.7%$39.3M-22.6%
Total Equity-$2.6Mn/m-$1.7Mn/m-$962Kn/m$349Kn/m-$1.5Mn/m-$5.5Mn/m-$4.2Mn/m-$2.9M-1677.8%
Retained Earnings-$84.6Mn/m-$83.7Mn/m-$82.9Mn/m-$81.8Mn/m-$84.8Mn/m-$88.4Mn/m-$87.0Mn/m-$85.1Mn/m

RHEP Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RHEP quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$2.0Mn/m$1.4M+143.8%-$890K-477.1%-$1.3M-232.8%-$1.8Mn/m$569K+12.7%$236K-60.5%$953K+278.2%
Depreciation & Amortization$785K+43.5%$757K+87.8%$722K+79.6%$712K+26.5%$547K+15.4%$403K-21.6%$402K-21.3%$563K+8.9%
Stock-Based Compensation$85K-31.5%$73K+192.0%$96K+336.4%N/A$124K$25K$22K-48.8%N/A
Capital Expenditures$706K+149.5%$498K+68.8%$364K+460.0%$226K+126.0%$283K+708.6%$295K-13.2%$65K+18.2%$100K+138.1%
Free Cash Flow$1.3Mn/m$889K+224.5%-$1.3M-833.3%-$1.5M-274.9%-$2.1Mn/m$274K+66.1%$171K-68.5%$853K+306.2%
Investing Cash Flow-$706K-112.4%-$498Kn/m-$364Kn/m$9.8Mn/m$5.7Mn/m-$295Kn/m-$65Kn/m-$100Kn/m
Financing Cash Flow-$976Kn/m-$388Kn/m-$735Kn/m-$6.4Mn/m-$3.1M-4246.7%-$121Kn/m-$587Kn/m-$883Kn/m

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

RHEP Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RHEP quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Margin-0.5%+3.4pp-0.9%+4.2pp-3.3%+1.1pp14.8%+5.3pp-3.9%+3.2pp-5.1%-10.0pp-4.4%+2.7pp9.6%+6.0pp
Net Margin-3.4%-25.7pp-3.2%+11.2pp-5.5%+20.5pp13.0%+23.0pp22.3%+45.6pp-14.4%+1.9pp-25.9%-2.6pp-10.0%-4.8pp
Return on EquityN/AN/AN/A773.4%N/AN/AN/AN/A
Return on Assets-1.3%-5.9pp-1.1%+1.3pp-1.7%+1.4pp4.0%+4.9pp4.7%+6.3pp-2.4%-1.3pp-3.1%-1.6pp-0.9%-0.6pp
Current Ratio0.640.650.640.67+0.3xN/AN/AN/A0.33
Debt-to-EquityN/AN/AN/A99.54N/AN/AN/AN/A
Liabilities-to-EquityN/AN/AN/A179.85N/AN/AN/AN/A
Asset Turnover0.37+0.2x0.36+0.2x0.31+0.2x0.31+0.2x0.21+0.1x0.17+0.1x0.12+0.1x0.090.0x
FCF Margin5.2%+18.9pp3.6%+0.9pp-5.9%-8.3pp-7.2%-22.3pp-13.8%-10.3pp2.7%-1.1pp2.4%-10.8pp15.1%+10.4pp

Not reported in any period shown, so not listed: Gross Margin.

Note: The current ratio is below 1.0 (0.67), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Regional Health Prtys Inc RHEP FY2025 $53.2M $3.0M 5.7% $3.6M —
HealthLynked Corp HLYK FY2025 $2.1M -$3.3M N/A $2.8M —
Syra Health Corp SYRA FY2025 $7.2M -$896K -12.4% $10.6M —
Adia Med Inc ADIA FY2025 $701K -$395K -56.5% $12.1M —
Elite Health Systems EHSI FY2025 $1.0M -$7.8M N/A $23.7M —
Cardiff Lexingtn Corp CDIX FY2025 $11.5M -$5.5M -47.7% $220K —

Frequently Asked Questions

Regional Health Prtys Inc (RHEP) reported $53.2M in total revenue for fiscal year 2025. This represents a 189.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Regional Health Prtys Inc (RHEP) revenue grew by 189.9% year-over-year, from $18.3M to $53.2M in fiscal year 2025.

No, Regional Health Prtys Inc (RHEP) reported a net loss of $91K over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $3.0M, with a net profit margin of 5.7%.

Regional Health Prtys Inc (RHEP) reported diluted earnings per share of $1.09 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Regional Health Prtys Inc (RHEP) had EBITDA of $3.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Regional Health Prtys Inc (RHEP) had $3.0M in cash and equivalents against $34.7M in long-term debt.

Regional Health Prtys Inc (RHEP) had an operating margin of 3.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Regional Health Prtys Inc (RHEP) had a net profit margin of 5.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Regional Health Prtys Inc (RHEP) has a return on equity of 872.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Regional Health Prtys Inc (RHEP) recorded an outflow of $3.1M in free cash flow during fiscal year 2025. This represents a -321.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Regional Health Prtys Inc (RHEP) recorded an outflow of $2.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Regional Health Prtys Inc (RHEP) had $67.8M in total assets as of fiscal year 2025, including both current and long-term assets.

Regional Health Prtys Inc (RHEP) invested $869K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Regional Health Prtys Inc (RHEP) had 4M shares outstanding as of fiscal year 2025.

Regional Health Prtys Inc (RHEP) had a current ratio of 0.67 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Regional Health Prtys Inc (RHEP) had a debt-to-equity ratio of 99.54 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Regional Health Prtys Inc (RHEP) had a liabilities-to-equity ratio of 179.85 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Regional Health Prtys Inc (RHEP) had a return on assets of 4.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Regional Health Prtys Inc (RHEP) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $3.6M as of Nov 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Regional Health Prtys Inc (RHEP) trades at 0.0x sales, its market capitalization divided by $91.4M revenue, trailing 12 months to September 30, 2026. The market capitalization is $3.6M as of Nov 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2025, Regional Health Prtys Inc (RHEP) held $3.0M in cash, cash equivalents and investments, and reported an operating cash outflow of $2.3M over that year. Dividing the one by the other, the reported balance equals about 16 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Regional Health Prtys Inc (RHEP) has an Altman Z-Score of -0.93, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Regional Health Prtys Inc (RHEP) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

For every $1 of reported earnings, Regional Health Prtys Inc (RHEP) used $0.74 of operating cash (-$2.3M OCF vs $3.0M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Regional Health Prtys Inc (RHEP) has an interest coverage ratio of 0.62x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top